RAC1 mutations are insufficient to drive melanoma and are almost always found with other activating MAP kinase hot spot mutations, most frequently NRAS (47%), BRAF [9,87,111], or NF1 [9,108,111,138]. Here, RAC1 is linked to melanoma.